Company:  DARA BIOSCIENCES, INC. (DARA)
Form Type:  10-Q
Filing Date:  8/14/2013 
CIK:  0000919745 
Address:  8601 SIX FORKS ROAD SUITE 160 
City, State, Zip:  RALEIGH, North Carolina 27615 
Telephone:  (816) 914-7027 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.88  
Change: 
0.00 (0.00%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$15.80M
Description of Business
DARA BioSciences, Inc. (NASDAQ: DARA) is a North-Carolina based specialty pharmaceutical company primarily focused on the commercialization of oncology treatment and oncology supportive care pharmaceutical products. Through our acquisition of Oncogenerix, Inc., which occurred on January 17, 2012, we acquired exclusive U.S. marketing rights to our first commercial, FDA-approved proprietary product Soltamox� (tamoxifen citrate) oral solution. Soltamox has been approved by the U.S. Food and Drug Administration (�FDA�) for the prevention and treatment of breast cancer. On September 7, 2012, we entered into a license agreement with Helsinn Healthcare SA (�Helsinn�) to distribute, promote, market and sell Gelclair�, a unique oral gel whose key ingredients are polyvinlypyrrolidone (PVP) and sodium hyaluronate (hyaluronic acid), for the treatment of certain approved indications in the United States. Gelclair is an FDA-cleared product indicated for the treatment of oral mucositis.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      ITEM 1. FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        STOCKHOLDERS EQUITY
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
      ITEM 4. CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      ITEM 1. LEGAL PROCEEDINGS
      ITEM 1A. RISK FACTORS
      ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      ITEM 3. DEFAULTS UPON SENIOR SECURITIES
      ITEM 4. MINE SAFETY DISCLOSURES.
      ITEM 5. OTHER
      ITEM 6. EXHIBITS
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO
  EXHIBIT 32
    CERTIFICATIONS OF
BROKERAGE PARTNERS